Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1995-04-24
1997-02-25
Walsh, Stephen G.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
424 851, C07K 14535, A61K 4505
Patent
active
056060246
ABSTRACT:
Compositions and methods for treating or preventing infections in canine or feline animals which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered variants of G-CSF may be the expression products of genetically engineered prokaryotic or eukaryotic host cells.
REFERENCES:
patent: 4810643 (1989-03-01), Souza
patent: 5472857 (1995-12-01), Boone et al.
Tsuchiya et al, "Isolation and Characterization of the cDNA for Murine Granulocyte Colony-Stimulating Factor", Immunobiology 172: 175-184 (1986).
Nagata et al., "The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor", EMBO Journal, 5(3): 575-581 (Mar. 1986).
Tsuchiya et al, "Characterization of recombinant human granulocyte colony-stimulating factor produced in mouse cells", EMBO Journal, 6(3): 611-616 (1987).
Neumeier and Maurer, "Isolation of a High Molecular Mass Granulocyte Colony-Stimulating Factor from Bovine Lung Conditioned Medium", Hoppe Seyler's Z. Physiol. Chemistry, 363: 1493-1500 (Dec. 1982).
Schuening et al., "Effect of Recombinant Granulocyte Colony-Stimulating Factor on Hematopoiesi of Normal Dogs and on Hematopoietic Recovery After Otherwise Lethal Total Body Irradiation", Blood, 74: 1308-1313 (1989).
Lothrop et al, "Correction of canine cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor", Chemical Abstracts, 109: 642-643 (1988).
Matsumoto, "Protective Effect of Human Granulocyte Colony-Stimulating Factor on Microbial Infection in Neutropenic Mice", Infection and Immunity, 55: 2715-2720 (1987).
Metcalf. 1991. Phil. Trans. R. Soc. Lond. B 333:147-173.
Hollingshead et al. 1991. Drugs 42:300-330.
Lothrop et al. 1988. Blood 72:1324-1328.
Pratt et al. 1990. Exp. Hematol. 18:1199-1203.
Scheuning et al. 1990. Blood 76:636-640.
Kurzman et al. 1992. Mol. Biotherm. 4:29-33.
Hammond et al. 1990. Blood 76:523-32.
Mishu et al. 1992. JAVMA 200:1957-1964.
Obradovich et al. 1991. J. Vet. Int. Med. 5:75-79.
Boone Thomas C.
Miller Allan L.
Amgen Inc.
Crandall Craig A.
Kemmerer Elizabeth C.
Levy Ron K.
Odre Steven M.
LandOfFree
Canine G-CSF polypeptides and pharmaceutical compositions compri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine G-CSF polypeptides and pharmaceutical compositions compri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine G-CSF polypeptides and pharmaceutical compositions compri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1974860